<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prognostic value of gene abnormalities in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is unclear, varies between investigators, and may be unreliable due to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> completely divided into biopsies to characterize the overall distribution of LOH at 5q, 17p, 18q, K-ras mutations, and methylation of the p16 and MGMT genes </plain></SENT>
<SENT sid="2" pm="."><plain>Seventeen <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (stage II-III) were completely divided into biopsy cubes from which DNA was sequentially analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>The results from fragment analysis for LOH at 5q, 17p, 18q, TGGE of the K-ras, and MSP for p16 and MGMT genes were used to characterize the occurrence of these aberrations </plain></SENT>
<SENT sid="4" pm="."><plain>LOH at 18q, 17p, and LOH 5q were present in 17/17, 15/17, and 15/16 tumors, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>p16 and MGMT were methylated in 16/17 and 14/17, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>The frequency of these aberrations varied largely between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>K-ras-mutations, present in 8/17 tumors, were much more consistently distributed in mutated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Methylation of p16 and MGMT and LOH at 18q, 17p, and 5q are present within the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass in a large majority of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and are of no or little prognostic value </plain></SENT>
<SENT sid="9" pm="."><plain>K-ras mutations appear more homogeneously distributed </plain></SENT>
<SENT sid="10" pm="."><plain>This has clinical relevance for biopsing to predict anti-EGFR response </plain></SENT>
</text></document>